Annual EBITDA
$583.00M$225.00M+62.85%
Summary
- Current Value
- As of today, NBIX annual EBITDA is $583.00M, up +62.85% on
- Historical Performance
- NBIX annual EBITDA is up +322.16% over the past 3 years, and up +578.70% over the past 5 years
- All-Time High Comparison
- NBIX annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- NBIX annual EBITDA is +146.41% above its 3-year low of $236.60M reached on an earlier date
- Sector Comparison
- NBIX annual EBITDA is higher than 91.95% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $583.00M | +62.9% | +322.2% | +578.7% | +1316.3% | |
| Quarterly EBITDA | $247.00M | +29.1% | +169.1% | +223.3% | +8330.0% | |
| TTM EBITDA | $583.30M | -5.0% | +160.6% | +67.0% | +2967.2% | |
| Price | $140.62 | +2.2% | +14.3% | +36.8% | +1777.4% | |
| PE Ratio | 33.58 | -19.7% | -58.0% | +35.8% | – | |
| Annual Revenue | $2.36B | +24.8% | +107.8% | +198.9% | +10000.0% | |
| Annual EPS | $3.29 | +33.1% | +259.6% | +751.3% | +353.2% | |
| Annual EBIT | $583.00M | +73.2% | +358.3% | +642.7% | +1240.6% | |
| Annual Net Income | $341.30M | +36.7% | +280.9% | +822.1% | +768.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $583.00M | at high | |
| 5Y | $583.00M | at high | |
| All | $583.00M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $236.60M | N/A | +146.4% |
| 5Y | $138.10M | +322.2% | |
| All | -$202.84M | +387.4% |
EBITDA History
FAQ
What is the current annual EBITDA of NBIX?
As of today, NBIX annual EBITDA is $583.00M
What is 1-year change in NBIX annual EBITDA?
NBIX annual EBITDA is up +62.85% year-over-year
What is 3-year change in NBIX annual EBITDA?
NBIX annual EBITDA is up +322.16% over the past 3 years
How far is NBIX annual EBITDA from its all-time high?
NBIX annual EBITDA is currently at its all-time high
How does NBIX annual EBITDA rank versus sector peers?
NBIX annual EBITDA is higher than 91.95% of companies in Healthcare sector
When is NBIX next annual earnings release?
The next annual earnings release for NBIX is on
Quarterly EBITDA
$247.00M$94.10M+61.54%
Summary
- Current Value
- As of today, NBIX quarterly EBITDA is $247.00M, up +61.54% on
- Historical Performance
- NBIX quarterly EBITDA is up +29.12% year-over-year, and up +169.06% over the past 3 years
- All-Time High Comparison
- NBIX quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- NBIX quarterly EBITDA is +689.14% above its 3-year low of $31.30M reached on
- Sector Comparison
- NBIX quarterly EBITDA is higher than 93.05% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $247.00M | +61.5% | +29.1% | +169.1% | +223.3% | |
| Annual EBITDA | $583.00M | – | +62.9% | +322.2% | +578.7% | |
| TTM EBITDA | $583.30M | +10.6% | -5.0% | +160.6% | +67.0% | |
| Price | $140.62 | +2.6% | +2.2% | +14.3% | +36.8% | |
| PE Ratio | 33.58 | +2.6% | -19.7% | -58.0% | +35.8% | |
| Quarterly Revenue | $794.90M | +15.6% | +27.8% | +104.9% | +207.5% | |
| Quarterly EPS | $2.04 | +92.0% | +64.2% | +195.4% | +431.1% | |
| Quarterly EBIT | $239.30M | +64.3% | +29.5% | +172.6% | +222.5% | |
| Quarterly Net Income | $209.50M | +94.9% | +61.4% | +205.8% | +463.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $247.00M | at high | |
| 3Y | $247.00M | at high | |
| 5Y | $247.00M | at high | |
| All | $247.00M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $31.30M | +689.1% | |
| 3Y | $31.30M | +689.1% | |
| 5Y | $6.40M | +3759.4% | |
| All | -$79.44M | +410.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of NBIX?
As of today, NBIX quarterly EBITDA is $247.00M
What is NBIX quarterly EBITDA most recent change?
NBIX quarterly EBITDA was up +61.54% on September 30, 2025
What is 1-year change in NBIX quarterly EBITDA?
NBIX quarterly EBITDA is up +29.12% year-over-year
How far is NBIX quarterly EBITDA from its all-time high?
NBIX quarterly EBITDA is currently at its all-time high
How does NBIX quarterly EBITDA rank versus sector peers?
NBIX quarterly EBITDA is higher than 93.05% of companies in Healthcare sector
When is NBIX next earnings release?
The next earnings release for NBIX is on
TTM EBITDA
$583.30M$55.70M+10.56%
Summary
- Current Value
- As of today, NBIX TTM EBITDA is $583.30M, up +10.56% on
- Historical Performance
- NBIX TTM EBITDA is down -5.00% year-over-year, and up +160.63% over the past 3 years
- All-Time High Comparison
- NBIX TTM EBITDA is currently -5.00% below its historical high of $614.00M set on
- 3-Year Low Comparison
- NBIX TTM EBITDA is +119.04% above its 3-year low of $266.30M reached on an earlier date
- Sector Comparison
- NBIX TTM EBITDA is higher than 91.16% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $583.30M | +10.6% | -5.0% | +160.6% | +67.0% | |
| Annual EBITDA | $583.00M | – | +62.9% | +322.2% | +578.7% | |
| Quarterly EBITDA | $247.00M | +61.5% | +29.1% | +169.1% | +223.3% | |
| Price | $140.62 | +2.6% | +2.2% | +14.3% | +36.8% | |
| PE Ratio | 33.58 | +2.6% | -19.7% | -58.0% | +35.8% | |
| TTM Revenue | $2.68B | +6.9% | +19.6% | +93.2% | +157.4% | |
| TTM EPS | $4.19 | +23.6% | +12.2% | +621.2% | +350.9% | |
| TTM EBIT | $553.60M | +10.9% | -5.9% | +164.1% | +62.5% | |
| TTM Net Income | $428.00M | +22.9% | +10.9% | +635.4% | +358.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $610.10M | N/A | -4.4% |
| 3Y | $614.00M | -5.0% | |
| 5Y | $614.00M | -5.0% | |
| All | $614.00M | -5.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $527.60M | +10.6% | |
| 3Y | $266.30M | N/A | +119.0% |
| 5Y | $179.30M | +225.3% | |
| All | -$219.91M | +365.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of NBIX?
As of today, NBIX TTM EBITDA is $583.30M
What is NBIX TTM EBITDA most recent change?
NBIX TTM EBITDA was up +10.56% on September 30, 2025
What is 1-year change in NBIX TTM EBITDA?
NBIX TTM EBITDA is down -5.00% year-over-year
How far is NBIX TTM EBITDA from its all-time high?
NBIX TTM EBITDA is currently -5.00% below its historical high of $614.00M set on September 30, 2024
How does NBIX TTM EBITDA rank versus sector peers?
NBIX TTM EBITDA is higher than 91.16% of companies in Healthcare sector
When is NBIX next earnings release?
The next earnings release for NBIX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- NBIX Official Website www.neurocrine.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/914475/000091447525000181/0000914475-25-000181-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/914475/000091447525000037/0000914475-25-000037-index.htm
- NBIX Profile on Yahoo Finance finance.yahoo.com/quote/NBIX
- NBIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbix